MF

Michael Freeman Raymond James Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
5
Avg Return
Past Year
51%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 100%
Neutral 0%
Negative 0%
Stock Rating Price Target Upside
Downside 		Ratings
1 Year 		Avg Return
1 Year 		Success Rate
1 Year 		Date
Outperform Assumed
$14
1%
upside
1 +91%
0 %
11 Jun ‘25 7 months ago
Outperform Reinstated
$76
270%
upside
1 -18%
0 %
11 Jun ‘25 7 months ago
Outperform Assumed
$37
108%
upside
1 +20%
0 %
11 Jun ‘25 7 months ago
Strong Buy Reinstated
$89
14%
upside
1 +47%
0 %
11 Jun ‘25 7 months ago
Strong Buy Initiated
$65
10%
downside
1 +115%
0 %
11 Jun ‘25 7 months ago